0001677576-26-000002
SEC filingMixed Q1: revenue and operating income declined on tenant defaults, but net income rose 5.6% on lower impairment and life science investment income.
Net cash provided by operating activities was $56.0 million, up from $54.2 million in the prior year, supported by life science investment income. The company continues to fund dividends and liquidity through operating cash flow and proceeds from preferred stock issuance under its ATM program.
Tenant defaults have expanded, with multiple tenants experiencing financial difficulties. The company has repossessed properties from defaulted tenants, leading to lower property expenses but also reduced rental income. Supply chain disruptions and geopolitical developments have resulted in longer lead times and increased costs for certain capital projects, which may delay development or redevelopment activities and the commencement or expansion of tenant operations. Inflationary pressures, changes in trade policy, and ongoing supply chain challenges have contributed to higher operating and capital costs for cannabis operators and, in certain cases, for the development or redevelopment of our properties. Changes in tariff policies may increase the cost of equipment, construction materials, and other inputs used in cultivation and production facilities.
The company sought to obtain an investment grade rating to facilitate access to the investment grade unsecured debt market as part of its overall strategy to maximize financial flexibility and manage its overall cost of capital. However, to the extent investments are funded with variable-rate indebtedness or other interest-sensitive capital sources, increases in interest rates may increase the cost of capital and reduce investment spreads. These higher costs may further affect tenant capital expenditure plans and operating margins. The extent of these impacts will continue to depend on broader economic conditions, regulatory developments, and future changes in trade and tariff policies. Repurchases under the share repurchase plan are expected to be funded from existing cash balances and proceeds from the sale of the Company's Series A Preferred Stock under its ATM Program.